Janssen Biotech, Inc.

Zemeda Ainekulu

John Lee

Ellen Chi

Wilson Edwards

Qiang Chen

Ann Lacombe

Paul H Kim

H Mimi Zhou

Matt Husovsky

Quynh Nguyen

In certain aspects, the disclosure relates to anti-idiotype antibodies and antigen-binding portions thereof that specifically bind a KL2B413 containing protein, e.g., an antibody or antigen-binding portions thereof. In some aspects, the anti-idiotype antibodies and antigen-binding portions of the present disclosure can be used in methods to detect and quantify cells expressing chimeric antigen receptors that include KL2B413.

Anti-idiotypic antibodies against anti-KLK2 antibodies

Growing community of inventors

San Diego, CA, United States of America

Zemeda Ainekulu